期刊文献+

5-Aza-CdR与低浓度CDDP联合用药对胃癌细胞系生长及DAPK1的影响 被引量:7

Effects of 5-Aza-CdR and low concentration CDDP on gastric cancer cell lines and expression of DAPK-1 gene
下载PDF
导出
摘要 目的研究5-Aza-CdR与低浓度CDDP联合用药对胃癌细胞系生长及DAPK1的影响。方法选择CDDP(1×10-6 mol/L)与1×10-6 mol/L的5-Aza-CdR分别处理体外培养的BGC823细胞与SCG7901细胞,5-Aza-CdR与CDDP联合处理体外培养的细胞后,用MTT法检测药物处理后的细胞增殖活性;RT-PCR法检测用药前后细胞中DAPK1的mRNA表达的变化。结果与单独用药组比较,胃癌细胞在药物联合作用组生长增殖活性明显被抑制。联合用药组DAPK-1基因的mRNA表达明显增加。结论 5-Aza-CdR与CDDP联用对胃癌细胞的生长抑制具有协同作用。 Objective To observe the effects of 5-Aza-CdR and low concentration CDDP on proliferation of human gastric cancer cell lines and the expression of DAPK-1 gene. Methods BGC823 and SCG7901 cells were cultured in RPMI1640,and they were treated with 5-Aza-CdR(1×10-6 mol/L),CDDP(1×10-6 mol/L),and both 5-Aza-CdR(1×10-6 mol/L)and CDDP(1×10-6 mol/L).The proliferation of the cells was detected by MTT assay.The expression of DAPK1 was detected by RT-PCR. Results Cells were exposed to 5-Aza-CdR(1×10-6 mol/L)and CDDP(1×10-6 mol/L),the growth of cells was inhibited more obviously.The expression of DAPK1 mRNA obviously increased in 5-Aza-CdR(1×10-6 mol/L)and CDDP(1×10-6 mol/L). Conclusion The gastric cancer cells growth treated with both 5-Aza-CdR and CDDP are inhibited more obviously.
出处 《实用药物与临床》 CAS 2011年第1期9-11,共3页 Practical Pharmacy and Clinical Remedies
关键词 5-AZA-CDR 顺铂(CDDP) DAPK1 胃癌 5-aza-2'-deoxycytidine(5-Aza-CdR) CDDP DAPK1 Gastric cancer
  • 相关文献

参考文献18

  • 1Kochi M,Fujii M,Kanamori N,et al. Neoadjuvant chemotherapy with S-1 and CDDP in advanced gastric cancer [J]. J Cancer Res Clin Oncol,2006,132(12) :781-785.
  • 2Matsuhashi N,Saio M,Matsuo A,et al. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis : time-and p53 expression-dependency of anti-cancer drugs[J].Oncol Rep,2005,14(3 ) :609-615.
  • 3Iioka Y, Mishima K, Azuma N, et al. Overexpression of protein kinase Cdelta enhances cisplatin-induced cytotoxicity correlated with p53 in gastric cancer cell line [ J ]. Pathobiology, 2005,72 (3) : 152-159.
  • 4Egger G, Aparicio AM, Escobar SG, et al. Inhibition of histone deacetylation does not block resilencing of p16 after 5-aza-2'- deoxycytidine treatment [ J]. Cancer Res, 2007,67 ( 1 ) : 346- 353.
  • 5Christoph F, Kempkensteffen C, Weikert S, et al. Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer [J]. Br J Cancer,2006,95(12) :1701-1707.
  • 6马韬.胃癌化疗与细胞凋亡研究进展[J].国外医学(消化系疾病分册),2003,23(1):15-18. 被引量:5
  • 7Francia G, Green SK, Bocci G, et al. Down-regulation of DNA mismatch repair proteins in human and murine tumor spheroids:implications for multicellular resistance to alkylating agents[ J]. Mol Cancer Ther,2005,4( 10):1484-1494.
  • 8Staub J,Chien J,Pan Y,et al. Epigenetic silencing of HSulf-1 in ovarian cancer:implications in chemoresistance [J ]. Oncogene,2007,19.
  • 9Bai T,Tanaka T,Yukawa K,et al. Int J Oncol. A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5- aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells. 2006,28 ( 2 ) :497-508.
  • 10Fang X, Zheng C, Liu Z, et al. Enhanced sensitivity of prostate cancer DU145 cells to cisplatinum by 5-aza-2'-deoxycytidine [ J ].Oncol Rep,2004,12 ( 3 ) :523-526.

二级参考文献20

  • 1Kaufmann SH, Eamshaw WC. Exp Cell Res, 2000 ;256(1): 42-49
  • 2Inada T, Ichikawa A, Igarashi S et al. J Surg Oncol, 1997;65(2): 106-110
  • 3Kondo S,Shnomura Y, Kanayama S et al. Oncogene, 1998; 17(20) :2585-2591
  • 4Sawa H, Kobayashi T, Mukai K et al. Int J Oncol, 2000; 16(4) :745-749
  • 5Nabeya Y, LoganzoF, MaslakPet al. IntJ Cancer, 1995;64(1):37-46
  • 6Litvak D, Papaconstantinou HT, Hwang KO et al. Surgery,1999; 126(2) :223-230
  • 7Kim R, Ohi Y, Inoue H et al. Anticancer Res, 1999; 19(6B):5399-5406
  • 8Kim R, Ohi Y, Inoue H et al. Anticancer Res, 2000 ;20 (1A):439-444
  • 9Motwani M, Delohery TM, Schwartz GK. Clin Cancer Res,1999;5(7): 1876- 1883
  • 10Kim R, Minami K, Nishimoto N et al. Int J Oncol, 2001;18(2): 363- 367

共引文献4

同被引文献55

引证文献7

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部